medRxiv preprint doi: https://doi.org/10.1101/2020.03.01.20029819; this version posted March 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth
Yi Li*, Meng Liang*, Xianhong Yin, Xiaoyu Liu, Meng Hao, Zixin Hu, Yi Wangâ€ , Li Jinâ€ .

*Contributed equally
â€ Joint Corresponding authors
Ministry of Education Key Laboratory of Contemporary Anthropology, Human
Phenome Institute, School of Life Sciences, Fudan University, China (Y Li, M Liang,
X Yin, X Liu, M Hao, Z Hu, Y Wang, Prof L Jinï¼‰
Institute for Six-sector Economy, Fudan University, Shanghai, China (Y Li, Prof L Jin)
Institute of Data Sciences, Fudan University (Prof L Jin)
Correspondence to:
Li Jin, Ministry of Education Key Laboratory of Contemporary Anthropology, Human
Phenome Institute, School of Life Sciences, Institute for Six-sector Economy and
Institute of Data Sciences, Fudan University, China, lijin@fudan.edu.cn;
Yi Wang, Ministry of Education Key Laboratory of Contemporary Anthropology,
Human Phenome Institute, School of Life Sciences, Fudan University, China,
wangyi_fudan@fudan.edu.cn.

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.03.01.20029819; this version posted March 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Summary
Background In December 2019, pneumonia infected with a novel coronavirus burst in
Wuhan, China. Now the situation is almost controlled in China but is worse outside
China. We aimed to build a mathematical model to capture the global trend of epidemics
outside China.
Methods In this retrospective, outside-China diagnosis number reported from Jan 21
to Feb 28, 2020 was downloaded from WHO website. We develop a simple regression
model on these numbers:
ğ‘™ğ‘œğ‘”!" (ğ‘# + 34) = 0 Â· 0515 Ã— ğ‘¡ + 2 Â· 075
where Nt is the total diagnosed patient till the ith day, t=1 at Feb 1.
Findings Based on this model, we estimate that there have been about 34 unobserved
founder patients at the beginning of spread outside China. The global trend is
approximately exponential, with the rate of 10 folds every 19 days.

Research in context
Evidence before this study
In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan,
China. Now the situation is almost controlled in China but is worse outside China.
Now there are 4,691 patients across 51 countries and territories outside China. We
searched PubMed and the China National Knowledge Infrastructure database for
articles published up to Feb 28, 2020, using the keywords â€œCOVIDâ€, â€œnovel
coronavirusâ€, â€œ2019-nCoVâ€ or â€œ2019 novel coronavirusâ€. No published work
about the global trend of epidemics outside China could be identified.
Added value of this study
We built a simple â€œlog-plusâ€ linear model to capture the global trend of epidemics
outside China. We estimate that there have been about 34 unobserved founder
patients at the beginning of spread outside China. The global trend is approximately
exponential, with the rate of 10 folds every 19 days.
Implications of all the available evidence
With the limited number of data points and the complexity of the real situation, a
straightforward model is expected to work better. Our model suggests that the
COVID-19 disease follows an approximate exponential growth model stably at the
very beginning. We predict that the number of confirmed patients outside China
will increase ten folds in every 19 days without strong intervention by applying our
model. Powerful actions on public health should be taken to combat this epidemic
all over the world.

medRxiv preprint doi: https://doi.org/10.1101/2020.03.01.20029819; this version posted March 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Introduction
In early December of 2019, pneumonia cases of unknown cause emerged in Wuhan, the
capital of Hubei province, China.1 A novel coronavirus (now named as COVID-19) was
verified and identified as the seventh member of enveloped RNA coronavirus (subgenus
sarbecovirus, Orthocoronavirinae subfamily) through high-throughput sequencing.2-4
Human-to-human transmission in hospital and family settings had been accumulating
5-7
and has occurred among close contacts since the middle of December 2019 based on
evidence from early transmission dynamics.8 According to WHO statistics, the
accumulating number of diagnosed patients in China was 78,961 in Feb 28, 2020.9
COVID-19 raised intension not only within China but internationally. Since the first
case of pneumonia caused by COVID-19 was reported from Wuhan, COVID-19
patients had rapidly been diagnosed in other cities of China and the neighboring
countries including Thailand, South Korea, Japan, and even to a few Western
countries.10-12 On January13 2020, the Ministry of Public Health of Thailand reported
the first imported case of lab-confirmed novel coronavirus (2019-nCoV). 13 As of Feb28
2020, cases had been reported in 52 countries and territories. The number of confirmed
COVID-19 cases had reached 4,691 outside China, 9 and the number is still increasing.
South Korea, the worst affected country outside China, has reported another jump. The
571 new cases brought South Koreaâ€™s total confirmed cases to 2,337. A surge in cases
of COVID-19 in Italy, Japan and Iran also heightened fears that the world is on the
brink of a pandemic.14 In Feb 28, WHO increased the assessment of the risk of spread
and risk of impact of COVID-19 to very high at the global level.
Recently, many researchers devoted to more details about the analysis of the spread
of epidemic.14,15 Some paralleled results have shown that the reproductive number R0
estimated of COVID-19 is bigger than that of SARS based on different models. 16-18
With the limited number of data points and the complexity of the real situation, a
straightforward model is expected to work better (see Discussion). In this study, we
propose a â€œlog-plusâ€ model for the situation prediction which only requires daily
number of total diagnosis outside China. This model assumes that there were some
unobserved founder patients at the beginning of spread outside China and exponential
growth later. Despite the simplicity of our model, it fits the data well (R2=0.991). The
prediction is expected to provide practical significance on social application and
evidence for enhancing public health interventions to avoid severe outbreaks.
Methods
Data
Daily diagnosis number of countries outside China is download from WHO situation
reports (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situationreports). The data in this analysis starts from Jan 21 and currently it ends at Feb 28.
Model
We first explored the data by plotting log transformed daily number. We observed a
good linear trend recently, but a relatively poor fit at the beginning of spread. We
therefore consider that there are some unobserved founder patients at the beginning.
Based on exploratory data analysis and mathematical intuition we proposed the
following model:
ğ‘™ğ‘œğ‘”!" (ğ‘# + ğ‘¢) = ğ‘ Ã— ğ‘¡ + ğ‘

medRxiv preprint doi: https://doi.org/10.1101/2020.03.01.20029819; this version posted March 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

where Nt is the number of diagnosed patients outside China according to WHO at the
tth day, t=1 at Feb 1; u is the number of unobserved founder patients at the beginning
of spread outside China; a and b are simple linear regression parameters. We
enumerated u from 0 to 100 with step size 1. For each u, we calculated Pearsonâ€™s
correlation R2 between t and ğ‘™ğ‘œğ‘”!" (ğ‘# + ğ‘¢) . We selected the ğ‘¢7 that maximize R2
and estimate corresponding ğ‘7 and ğ‘8 using a simple linear regression between t and
ğ‘™ğ‘œğ‘”!" (ğ‘# + ğ‘¢7).
Availability of source code
The source code of model estimation is at: https://github.com/wangyi-fudan/COVID19_Global_Model

Results
Data Table
The WHO daily count of diagnosis number outside China and its â€œlog-plusâ€ transform
as well as model fit were shown in table 1.
Date
t
21-Jan -10
22-Jan -9
23-Jan -8
24-Jan -7
25-Jan -6
26-Jan -5
27-Jan -4
28-Jan -3
29-Jan -2
30-Jan -1
31-Jan 0
1-Feb
1
2-Feb
2
3-Feb
3
4-Feb
4
5-Feb
5
6-Feb
6
7-Feb
7
8-Feb
8
9-Feb
9
10-Feb 10
11-Feb 11
12-Feb 12
13-Feb 13
14-Feb 14
15-Feb 15

Nt
4
4
7
11
23
29
37
56
68
82
106
132
146
153
159
191
216
270
288
307
319
395
441
447
505
526

log10(Nt+34) model fit
1Â·580
1Â·559
1Â·580
1Â·611
1Â·613
1Â·662
1Â·653
1Â·714
1Â·756
1Â·765
1Â·799
1Â·817
1Â·851
1Â·868
1Â·954
1Â·920
2Â·009
1Â·971
2Â·064
2Â·023
2Â·146
2Â·075
2Â·220
2Â·126
2Â·255
2Â·178
2Â·272
2Â·229
2Â·286
2Â·281
2Â·352
2Â·332
2Â·398
2Â·384
2Â·483
2Â·435
2Â·508
2Â·487
2Â·533
2Â·538
2Â·548
2Â·590
2Â·632
2Â·641
2Â·677
2Â·693
2Â·682
2Â·744
2Â·732
2Â·796
2Â·748
2Â·847

medRxiv preprint doi: https://doi.org/10.1101/2020.03.01.20029819; this version posted March 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

16-Feb
17-Feb
18-Feb
19-Feb
20-Feb
21-Feb
22-Feb
23-Feb
24-Feb
25-Feb
26-Feb
27-Feb
28-Feb

16
17
18
19
20
21
22
23
24
25
26
27
28

683
794
804
924
1,073
1,200
1,402
1,769
2,069
2,459
2,918
3,664
4,691

2Â·856
2Â·918
2Â·923
2Â·981
3Â·044
3Â·091
3Â·157
3Â·256
3Â·323
3Â·397
3Â·470
3Â·568
3Â·674

2Â·899
2Â·950
3Â·002
3Â·053
3Â·105
3Â·156
3Â·208
3Â·259
3Â·311
3Â·362
3Â·414
3Â·466
3Â·517

Table 1: WHO Daily Diagnosis Number Outside China
Parameter Estimation
ğ‘¢7 , ğ‘7 and ğ‘8 were estimated as 34, 0Â·0515 and 2Â·075 respectively according to Feb
28 data (figure 1)

Figure 1: Estimation of u Parameter by Enumeration
Global Trend Model
We plot ğ‘™ğ‘œğ‘”!" (ğ‘# + 34) against time to visualize the model fitting (figure 2). The
model R2 is 0Â·991 indicating an excellent model fit.

medRxiv preprint doi: https://doi.org/10.1101/2020.03.01.20029819; this version posted March 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 2: The Exponential Growth of COVID-19 Infection Outside China
Future Number Prediction
Currently the number of diagnoses at Febuary 28 is 4,691. We predict that the number
of diagnoses outside China will expand exponentially with the rate of 10 folds every 19
days without strong intervention.
Conclusion
Based on this model, we estimated that there have been about 34 unobserved founder
patients at the beginning of spread outside China. Our model suggests that the COVID19 disease follows an approximate exponential growth model stably at the very
beginning. The situation is dangerous as we expect 10 folds increases of patients every
19 days without strong intervention. We call on world-wide strong actions on public
health referring to experiences learnt from China and Singapore.
Discussion
In this report, we only analyzed the total number of diagnoses outside China. The
country scale data is available but is not as complete as total number. Here, we limited
this analysis to capture the global trend.
This model is a minimal extension of the â€˜defaultâ€™ exponential growth model with
the estimation of 34 unobserved founder patients outside China. An almost perfect
model fitting (R2=0Â·991) indicates that the spread of disease does follow our model.
A simple and straightforward linear model inherits with some advantages: (1) it
works on small sample size due to limited observation or somewhat unperfect data. (2)
it is relatively robust in complex situations. The virus spreading pattern is complex and
yet varies across the world. A simple model simplified the situation and provides
coarse-grained trend estimation. (3) A linear model has nice extrapolation ability
comparing to complex models (e.g. Neural network).
The existent of 34 unobserved founder patients is not surprising. They may have mild
symptoms thus did not went to the hospitals. However, we did not preclude the

medRxiv preprint doi: https://doi.org/10.1101/2020.03.01.20029819; this version posted March 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

possibility that they already existed before or parallel with Wuhanâ€™s burst.
Contributors
YW conceived the idea and wrote the source code. YW, YL, ML and LJ contributed
data analysis, generating tables and figures, and manuscript writing. YL, ML, XY, LX,
MH, ZH, YW, LJ contributed the theoretical analysis and manuscript revision. All
authors contributed to final revision of the manuscript.
Declaration of interests
The authors declare that the research was conducted in the absence of any commercial
or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We thank the Fudan University High-End Computing Center for supporting
computations involved in this study.
References
1. Huang C, Wang Y, Li X, et al. Clinical features of patients with 2019 novel
coronavirus in Wuhan, China. Lancet. 2020; doi: 10.1016/S0140-6736(20)30183-5
2. Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel
coronavirus: implications of virus origins and receptor binding. Lancet. 2020; doi:
10.1016/S0140-6736(20)30251-8
3. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-themedia-briefing-on-2019-ncov-on-11-february-2020
4. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia
in China, 2019. N Engl J Med. 2020; doi: 10.1056/NEJMoa2001017
5. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with
the 2019 novel coronavirus indicating person-to-person transmission: a study of a
family cluster. Lancet. 2020; doi: 10.1016/S0140-6736(20)30154-9
6. Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human
transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020; doi:
10.1056/NEJMc2001272
7. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic
and international spread of the 2019-nCoV outbreak originating in Wuhan, China:
A modeling study. Lancet. 2020;
8. Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel
Coronavirus-Infected Pneumonia. N Engl J Med 2020; published online. doi:
10.1056/NEJMoa2001316
9. https://www.who.int/docs/default-source/coronaviruse/situationreports/20200226-sitrep-37-covid-19.pdf?sfvrsn=2146841e_2
10. Kim H. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists?
2020.
11. Shao N, Pan H, Li X, et al. CoVID-19 in Japan: What could happen in the future?
medRxiv, 2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.03.01.20029819; this version posted March 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

12. Ryu S, Ali S T, Lim J, et al. The estimate of infected individuals of the 2019-Novel

13.
14.

15.
16.
17.

18.

Coronavirus in South Korea by incoming international students from the countries
of risk of 2019-Novel Coronavirus: a simulation study. medRxiv, 2020.
https://www.who.int/docs/default-source/coronaviruse/situationreports/20200227-sitrep-38-covid-19.pdf?sfvrsn=9f98940c_2
Shao N, Cheng J, Chen W. The reproductive number R0 of COVID-19 based on
estimate of a statistical time delay dynamical system. medRxiv 2020;
doi:10.1101/2020.02.17.20023747 (preprint).
Zhao Q, Chen Y, Small D S. Analysis of the epidemic growth of the early 2019nCoV outbreak using internationally confirmed cases. medRxiv, 2020.
Xiong H, Yan H. Simulating the infected population and spread trend of 2019-nCov
under different policy by EIR model. Available at SSRN 3537083, 2020.
Mizumoto K, Kagaya K, Chowell G. Early epidemiological assessment of the
transmission potential and virulence of 2019 Novel Coronavirus in Wuhan City:
China, 2019-2020. medRxiv, 2020.
Zhao S. et al. Preliminary estimation of the basic reproduction number of novel
coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in
the early phase of the outbreak. International Journal of Infectious Diseases, 2020.

